Jaguar Health, Inc. filed a Certificate of Designation for 1,557,000 shares of Series O Convertible Preferred Stock with the Secretary of State of Delaware on March 2, 2026. This filing is in connection with a previously announced special one-time dividend of one-tenth of one share of Series O Preferred Stock for each share of voting common stock and certain eligible warrants. The record date for the dividend was March 2, 2026, with payment expected as of the close of business on March 4, 2026. Series O Preferred Stock has a par value of $0.0001 per share and a Stated Value of $8.01 for conversion purposes. Holders are not entitled to receive dividends on Series O Preferred Stock and have limited voting rights (one vote per one-tenth of one share when entitled to vote). The company may optionally convert all Series O Preferred Stock to common stock before December 31, 2026, or it will automatically convert on December 31, 2026. Conversion is subject to a 19.99% beneficial ownership limitation, with pre-funded warrants issued for any excess shares. There is no established trading market for Series O Preferred Stock, and the company does not expect one to develop or intend to list it on any securities exchange.